
Spermosens Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Spermosens
Access all reports
Spermosens AB is a Sweden-based medical technology company focused on fertility diagnostics. The company develops innovative solutions aimed at improving the understanding and treatment of male infertility. Spermosens’ technology centers on analyzing sperm function and compatibility with the egg, providing valuable insights for assisted reproductive treatments such as in vitro fertilization (IVF). The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
SPERM
Country
🇸🇪 Sweden